Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

June 29, 2020 by Alan Khadavi

Breztri new inhaler for COPD by AstraZeneca

Breztri is a new inhaler that will be approved for COPD. Breztri is a combination of 3 medications, budesonide/glycopyrronium/formoterol fumarate. Each of these medications have been used to treat COPD (chronic obstructive pulmonary disease), and used in combination, it has been shown to decrease the rate of moderate or severe exacerbations.

We have spoken about another triple therapies in the past:

Trelegy, New Asthma Triple Therapy to be Released by GSK

Trimbow Triple Combination For COPD and Asthma by Chiesi

Breztri Aerosphere consists of 3 medications:

  1. Budesonide-a steroid inhaler
  2. glycopyrronium-muscarinic anticholinergic group
  3. Formoterol fumarate-a Long acting beta-2-agonist

Studies have shown that Breztri Aerosphere was well tolerated, the most frequent adverse events were nasopharyngitis, COPD and upper respiratory tract infection.

“The Phase III ETHOS trial results are exciting and demonstrate that Breztri Aerosphere significantly reduces the rate of exacerbations,” stated Klaus Rabe, professor of Pulmonary Medicine at the University of Kiel, director of the Department of Pneumology at Clinic Grosshansdorf, Germany, and lead investigator of the ETHOS trial. “This is also the first time we have seen the benefit of fixed-dose triple-combination therapy at two inhaled corticosteroid doses, which could transform treatment practice by allowing physicians to select the optimal dose for individual patients.”

ETHOS is part of AstraZeneca’s ATHENA clinical trial program for Breztri Aerosphere, which has more than 15,500 patients around the world in 11 clinical trials. The four primary trials are ETHOS, KRONOS, TELOS and SOPHOS.

A major question for these triple therapy medications is whether or not they will be approved for asthma. Current asthma medications like Advair, Symbicort, Dulera, Breo and AirDuo contain both inhaled steroids and a long acting beta agonist. The 3rd ingredient the anticholenergic in these medications have not been given FDA approval yet in these fixed products.  Allergists do currently use them in some difficult to control asthmatic patients, Spiriva is one that is commonly used currently.

Breztri Aerosphere should be out soon, AstraZeneca currently has a website set up for its latest news.

 

Filed Under: Asthma, Blog

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page